HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takahiro Tsuboyama Selected Research

Takahiro Tsuboyama Research Topics

Disease

5Neoplasms (Cancer)
01/2020 - 06/2010
2Endometrial Neoplasms (Endometrial Cancer)
05/2018 - 01/2011
2Hepatocellular Carcinoma (Hepatoma)
04/2012 - 06/2010
1Colorectal Neoplasms (Colorectal Cancer)
01/2022
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2022
1Ovarian Torsion
03/2019
1Adenocarcinoma
09/2017
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2016
1Endometrioid Carcinoma
01/2015
1Liver Diseases (Liver Disease)
04/2012
1Stomach Neoplasms (Stomach Cancer)
05/2011
1Neoplasm Metastasis (Metastasis)
05/2011
1Carcinoma (Carcinomatosis)
01/2011
1Leiomyoma (Uterine Fibroids)
01/2011

Drug/Important Bio-Agent (IBA)

4gadolinium ethoxybenzyl DTPAFDA Link
01/2020 - 06/2010
1Imatinib Mesylate (Gleevec)FDA Link
01/2022
1iopromide (Ultravist)FDA Link
01/2020
1GasesIBA
09/2018
1Gadolinium DTPA (Magnevist)FDA Link
09/2018
1GemcitabineFDA Link
09/2017
1Glucose (Dextrose)FDA LinkGeneric
09/2017
1Complement System Proteins (Complement)IBA
08/2014
1AntralIBA
05/2011
1N 30IBA
01/2011
1Organic Anion TransportersIBA
06/2010
1Multidrug Resistance-Associated Protein 2IBA
06/2010
1Peptides (Polypeptides)IBA
06/2010

Therapy/Procedure

2Laparotomy
03/2019 - 05/2011
2Therapeutics
05/2018 - 05/2011
1Injections
01/2020
1Chemoradiotherapy
09/2017
1Neoadjuvant Therapy
09/2017
1Drug Tapering
01/2016
1Curettage
01/2015